navtemadlin
Phase 1- Indications
- Glioblastoma
Company intelligence / Profile preview
Travera
Medford, Massachusetts, United Statestravera.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Early studies show 80% predictive accuracy in matching actual responses of cancer treatments. Multiple clinical validation studies are ongoing at major medical institutions throughout the United States.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic testingPersonalized cancer treatment
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Major medical institutions throughout the United States
Beyond the preview
Go deeper on Travera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Travera.